3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
19
Breast Neoplasms
18
Fallopian Tube Neoplasms
13
Neoplasm Metastasis
10
Triple Negative Breast Neoplasms
8
Prostatic Neoplasms
8
Neoplasms
7
Endometrial Neoplasms
7
Small Cell Lung Carcinoma
5
Pancreatic Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Metastatic Castration-resistant Prostate Cancer
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Solid Tumors
3
Neuroendocrine Tumors
3
Lymphoma, Non-Hodgkin
3
Lung Neoplasms
3
Glioma
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Osteosarcoma
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Glioblastoma
2
Ependymoma
2
Interventions
Specimen Handling
5
Biopsy
5
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
Azacitidine
3
venetoclax
2
ruxolitinib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Decitabine
2
Busulfan
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
iadademstat
1
gilteritinib
1
fludarabine
1
fedratinib
1
axatilimab
1
Tranexamic Acid
1
Topotecan
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
olaparib
×
90 days
×
Clear all
No trials found.